Results 1 to 10 of about 200,238 (297)

Somatic point mutation calling in low cellularity tumors. [PDF]

open access: yesPLoS ONE, 2013
Somatic mutation calling from next-generation sequencing data remains a challenge due to the difficulties of distinguishing true somatic events from artifacts arising from PCR, sequencing errors or mis-mapping.
Karin S Kassahn   +33 more
doaj   +7 more sources

Differences between germline and somatic mutation rates in humans and mice

open access: yesNature Communications, 2017
Germline mutation rates are known to vary between species but somatic mutation rates are less well understood. Here the authors compare mice and humans, observing that somatic mutation rates were nearly two orders of magnitude higher in both species ...
Brandon Milholland   +5 more
doaj   +2 more sources

Somatic mutations substantially increase the per‐generation mutation rate in the conifer Picea sitchensis

open access: yesEvolution Letters, 2019
The rates and biological significance of somatic mutations have long been a subject of debate. Somatic mutations in plants are expected to accumulate with vegetative growth and time, yet rates of somatic mutations are unknown for conifers, which can ...
Vincent C. T. Hanlon   +2 more
doaj   +2 more sources

Somatic mutation rates scale with time not growth rate in long-lived tropical trees [PDF]

open access: yeseLife
The rates of appearance of new mutations play a central role in evolution. However, mutational processes in natural environments and their relationship with growth rates are largely unknown, particular in tropical ecosystems with high biodiversity. Here,
Akiko Satake   +14 more
doaj   +2 more sources

Somatic Mutations and Autoimmunity [PDF]

open access: yesCells, 2021
Autoimmune diseases are among the most common chronic illness caused by a dysregulated immune response against self-antigens. Close to 5% of the general population in Western countries develops some form of autoimmunity, yet its underlying causes, although intensively studied, are still not fully known, and no curative therapies exist.
Maha Alriyami, Constantin Polychronakos
openaire   +3 more sources

Bayesian networks elucidate complex genomic landscapes in cancer

open access: yesCommunications Biology, 2022
Bayesian network inference on several blood and solid cancer genomic datasets provides more accessible ways to explore driver events in cancer.
Nicos Angelopoulos   +4 more
doaj   +1 more source

Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells

open access: yesNature Communications, 2022
Inherited mutations in MUTYH have been shown to predispose patients to colorectal cancers. Here, the authors show that MUTYH mutations lead to an increased somatic base substitution mutation rate in normal intestinal epithelial cells, which is the likely
Philip S. Robinson   +25 more
doaj   +1 more source

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates

open access: yesMolecular Cancer, 2022
Background Up to 80% of cases of prostate cancer present with multifocal independent tumour lesions leading to the concept of a field effect present in the normal prostate predisposing to cancer development.
Claudia Buhigas   +26 more
doaj   +1 more source

Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients

open access: yesNature Communications, 2021
The mechanisms that shape the regulatory T cell repertoire in patients with cancer are not completely understood. Here, the authors observe that, in breast cancer patients, tumor-resident regulatory T cells do not show clonal relationship with their ...
Maria Xydia   +24 more
doaj   +1 more source

Home - About - Disclaimer - Privacy